首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1922436

日本重組蛋白市場報告：按產品、應用、最終用戶和地區分類（2026-2034年）

Japan Recombinant Protein Market Report by Product, Application, End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 118 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本重組蛋白市場規模達2.894億美元。 IMARC Group預測，到2034年，該市場規模將達到6.007億美元，2026年至2034年的複合年成長率（CAGR）為8.46%。推動市場成長的主要因素是生物製藥（如單株抗體、疫苗和治療性蛋白質）的不斷發展，這些產品擴大被用於治療包括癌症、自體免疫疾病和感染疾病的各種疾病。

重組蛋白是一種人工工程蛋白，它是透過將來自不同來源的遺傳物質（通常是能夠產生特定蛋白質的生物體的DNA）與宿主生物體的細胞蛋白質合成機制結合而產生的。這個過程在生物技術和製藥行業至關重要，它能夠大規模生產用於各種應用的特定蛋白質。為了建構重組蛋白，科學家將所需的基因序列導入宿主生物體，例如細菌、酵母或哺乳動物細胞。一旦宿主生物體吸收了外源DNA，它就會根據插入的遺傳訊息開始合成目標蛋白。重組蛋白的應用十分廣泛，包括治療藥物（例如胰島素和疫苗）、研究工具（例如酵素和抗體）以及用於各種製程（例如生質燃料生產和食品加工）的工業酵素。它們的生產具有精確控制、擴充性和高純度等優點，使其成為醫學、科學和工業進步的關鍵。

日本重組蛋白市場趨勢：

推動日本重組蛋白市場發展的因素很多。首先，癌症、糖尿病和自體免疫疾病等慢性病的日益增多，推動了對採用重組DNA技術生產的治療性蛋白質的需求。因此，製藥公司正大力投資新型生物製藥的研發，進而促進了市場成長。此外，基因工程和生物技術的進步也改進了重組蛋白的生產過程。細胞株和酵母細胞株等表達系統的改進，使得複雜蛋白的生產產量和品質均有所提高，從而推動了市場擴張。同時，蛋白質體學和基因體學領域研發活動的蓬勃發展，也推動了作為研究工具的重組蛋白的需求。這些蛋白質對於研究基因功能、闡明蛋白質-蛋白質相互作用以及藥物發現至關重要，進一步促進了市場成長。此外，個人化醫療的引入以及雙特異性抗體和融合蛋白的開發，為治療性蛋白質產業帶來了新的機遇，預計這些因素將在預測期內推動日本重組蛋白市場的發展。

本報告解答的關鍵問題：

迄今為止，日本重組蛋白市場的發展趨勢是什麼？您預計未來幾年該市場的發展趨勢會如何？
新冠疫情對日本重組蛋白市場產生了哪些影響？
日本重組蛋白市場依產品分類的組成是怎樣的？
日本重組蛋白市場依應用領域分類的組成是怎樣的？
日本重組蛋白市場依最終用戶分類的市場組成為何？
請介紹日本重組蛋白市場價值鏈的各個環節。
日本重組蛋白市場的主要促進因素和挑戰是什麼？
日本重組蛋白市場的結構是怎麼樣的？主要參與者有哪些？
日本重組蛋白市場競爭有多激烈？

Japan recombinant protein market size reached USD 289.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 600.7 Million by 2034, exhibiting a growth rate (CAGR) of 8.46% during 2026-2034. The inflating development of biopharmaceuticals, such as monoclonal antibodies, vaccines, and therapeutic proteins, which are increasingly being used to treat various illnesses, including cancer, autoimmune disorders, and infectious diseases, is driving the market.

Recombinant protein are artificially engineered proteins created by combining genetic material from different sources, typically DNA from one organism with the ability to produce a specific protein and the host organism's cellular machinery for protein production. This process is integral to the biotechnology and pharmaceutical industries, allowing the large-scale production of specific proteins for various applications. To create recombinant proteins, scientists insert the desired gene sequence into a host organism, like bacteria, yeast, or mammalian cells. Once the host organism takes up the foreign DNA, it begins producing the target protein according to the inserted genetic instructions. Recombinant proteins have diverse applications, including the production of therapeutic drugs (e.g., insulin or vaccines), research tools (e.g., enzymes and antibodies), and industrial enzymes for various processes (e.g., biofuel production or food processing). Their production allows for precise control, scalability, and purity, making them essential in advancing medical, scientific, and industrial fields.

Japan Recombinant Protein Market Trends:

Several factors drive the recombinant protein market in Japan. Firstly, the increasing incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has created a growing demand for therapeutic proteins produced through recombinant DNA technology. Consequently, pharmaceutical companies are heavily investing in the development of novel biopharmaceuticals, propelling the market forward. Furthermore, advancements in genetic engineering and biotechnology have led to improved production processes for recombinant proteins. Enhanced expression systems, such as mammalian and yeast cell lines, have enabled the production of complex proteins with higher yields and better quality, driving market expansion. In addition to this, the surge in R&D activities in the field of proteomics and genomics has boosted the demand for recombinant proteins as research tools. These proteins are essential for studying gene function, protein-protein interactions, and drug discovery, fostering market growth. Moreover, the adoption of personalized medicine and the development of bi-specific antibodies and fusion proteins, which have opened up new opportunities in the therapeutic protein industry, is expected to drive the recombinant protein market in Japan during the forecast period.

Japan Recombinant Protein Market Segmentation:

Product Insights:

Antibodies
Hormones
Growth Factors
Cytokines
Others

Application Insights:

Drug Discovery and Development
Academic Research
Biotechnology Research
Biopharmaceutical Production
Others

End User Insights:

Pharmaceutical and Biopharmaceutical Companies
Biotechnology Companies
Academic and Research Institutes
Contract Research Organization
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan recombinant protein market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan recombinant protein market?
What is the breakup of the Japan recombinant protein market on the basis of product?
What is the breakup of the Japan recombinant protein market on the basis of application?
What is the breakup of the Japan recombinant protein market on the basis of end user?
What are the various stages in the value chain of the Japan recombinant protein market?
What are the key driving factors and challenges in the Japan recombinant protein?
What is the structure of the Japan recombinant protein market and who are the key players?
What is the degree of competition in the Japan recombinant protein market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Recombinant Protein Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Recombinant Protein Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Recombinant Protein Market - Breakup by Product

6.1 Antibodies
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Hormones
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Growth Factors
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
6.4 Cytokines
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)
6.5 Others
- 6.5.1 Historical and Current Market Trends (2020-2025)
- 6.5.2 Market Forecast (2026-2034)

7 Japan Recombinant Protein Market - Breakup by Application

7.1 Drug Discovery and Development
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Academic Research
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Biotechnology Research
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Biopharmaceutical Production
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2020-2025)
- 7.5.2 Market Forecast (2026-2034)

8 Japan Recombinant Protein Market - Breakup by End User

8.1 Pharmaceutical and Biopharmaceutical Companies
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Biotechnology Companies
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Academic and Research Institutes
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Contract Research Organization
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2020-2025)
- 8.5.2 Market Forecast (2026-2034)

9 Japan Recombinant Protein Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Breakup by Product
- 9.1.4 Market Breakup by Application
- 9.1.5 Market Breakup by End User
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2026-2034)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Breakup by Product
- 9.2.4 Market Breakup by Application
- 9.2.5 Market Breakup by End User
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2026-2034)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Breakup by Product
- 9.3.4 Market Breakup by Application
- 9.3.5 Market Breakup by End User
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2026-2034)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Breakup by Product
- 9.4.4 Market Breakup by Application
- 9.4.5 Market Breakup by End User
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2026-2034)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Breakup by Product
- 9.5.4 Market Breakup by Application
- 9.5.5 Market Breakup by End User
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2026-2034)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Breakup by Product
- 9.6.4 Market Breakup by Application
- 9.6.5 Market Breakup by End User
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2026-2034)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2020-2025)
- 9.7.3 Market Breakup by Product
- 9.7.4 Market Breakup by Application
- 9.7.5 Market Breakup by End User
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2026-2034)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2020-2025)
- 9.8.3 Market Breakup by Product
- 9.8.4 Market Breakup by Application
- 9.8.5 Market Breakup by End User
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2026-2034)

10 Japan Recombinant Protein Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Recombinant Protein Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis